Cost-effectiveness of Escitalopram vs. Venlafaxin XR in the treatment of major depressive disorder in Germany

被引：1

作者：

Kulp, W ^{[1
]}

Greiner, W ^{[1
]}

Schulenburg, JM ^{[1
]}

机构：

[1] Univ Hannover, Hannover, Germany

来源：

VALUE IN HEALTH | 2005年 / 8卷 / 03期

关键词：

D O I：

10.1016/S1098-3015(10)63062-8

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：392 / 393

页数：2

共 50 条

[21] Cost-effectiveness analysis of escitalopram: a new SSRI in the first-line treatment of major depressive disorder in Austria
Hemels, MEH
Kasper, S
Walter, E
Einarson, TR
CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (06) : 869 - 878
[22] A cost-effectiveness model of escitalopram, citalopram, and venlafaxine as first-line treatment for major depressive disorder in Belgium
Demyttenaere, K
Hemels, MEA
Hudry, J
Annemans, L
CLINICAL THERAPEUTICS, 2005, 27 (01) : 111 - 124
[23] COST-EFFECTIVENESS OF ESCITALOPRAM VERSUS VENLAFAXINE IN SECOND-LINE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) IN SWEDEN
Despiegel, N.
Danchenko, N.
Maman, K.
VALUE IN HEALTH, 2009, 12 (03) : A177 - A177
[24] Cost effectiveness analysis of escitalopram compared to venlafaxine and fluvoxamine in treatment of major depressive disorder
Xie, Feng
Despiegel, Nicolas
Danchenko, Natalya
Hansen, Karina
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2009, 13 (01) : 59 - 69
[25] Cost effectiveness of duloxetine compared with venlafaxine-XR in the treatment of major depressive disorder
Van Baardewijk, M
Vis, PM
Einarson, T
VALUE IN HEALTH, 2005, 8 (06) : A209 - A210
[26] Cost effectiveness of duloxetine compared with venlafaxine-XR in the treatment of major depressive disorder
van Baardewijk, M
Vis, PMJ
Einarson, TR
CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (08) : 1271 - 1279
[27] Cost-Effectiveness of a Pharmacogenetic Test to Guide Treatment for Major Depressive Disorder
Groessl, Erik J.
Tally, Steven R.
Hillery, Naomi
Maciel, Alejandra
Garces, Jorge A.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (08): : 726 - 734
[28] Double-blind comparison of escitalopram and venlafaxine XR in the treatment of major depressive disorder
Bielski, R
Ventura, D
Chang, C
Korotzer, A
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S263 - S263
[29] Probabilistic cost-effectiveness model of escitalopram compared with citalopram and venlafaxine in primary care treatment of major depressive disorder in Denmark.
Hemels, MEH
Sorensen, J
Stage, KB
Damsbo, N
LeLay, A
NORDIC JOURNAL OF PSYCHIATRY, 2005, 59 (05) : 412 - 412
[30] A probabilistic cost-effectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the UK
Wade, AG
Toumi, I
Hemels, MEH
CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (04) : 631 - 641

← 1 2 3 4 5 →